title: Phase II study of topotecan and cyclophosphamide in patients with relapsed and refractory multiple myeloma.
authors.forename: Eric H
authors.initials: EH
authors.lastname: Kraut
authors.forename: Donn
authors.initials: D
authors.lastname: Young
authors.forename: Sherif
authors.initials: S
authors.lastname: Farag
authors.forename: Arthur G
authors.initials: AG
authors.lastname: James
authors.forename: Richard J
authors.initials: RJ
authors.lastname: Solove
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000008:administration & dosage; D019008:Drug Resistance, Neoplasm; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy*; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy*; D016879:Salvage Therapy; D019772:Topotecan / Q000008:administration & dosage; D017211:Treatment Failure
chemical_list: D019772:Topotecan; D003520:Cyclophosphamide